Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001231615-25-000008

Director sold 13,464 shares at $123.68 ($1,665,228)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

JEFFS ROGER · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-02 Sale : show line 1 in the form 10b5-1 −13,464 $123.68 $1,665,228 57,510 D
Open-market sales · 13,464 sh · avg $123.68 · $1,665,228
Loading xslF345X05/ownership.xml…